Graft quality assessment in kidney transplantation: not an exact science yet!

PubWeight™: 0.86‹?›

🔗 View Article (PMID 21383549)

Published in Curr Opin Organ Transplant on April 01, 2011

Authors

Ina Jochmans1, Jacques Pirenne

Author Affiliations

1: Department of Abdominal Transplant Surgery, University Hospitals Leuven, KULeuven, Leuven, Belgium. ina.jochmans@med.kuleuven.be

Articles by these authors

Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med (2009) 5.26

Intrarenal resistive index after renal transplantation. N Engl J Med (2013) 4.19

Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes. Hepatology (2012) 2.49

Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation. J Clin Invest (2011) 2.36

Machine perfusion versus cold storage for preservation of kidneys from expanded criteria donors after brain death. Transpl Int (2011) 2.25

Keratin 19: a key role player in the invasion of human hepatocellular carcinomas. Gut (2013) 2.10

Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients. Hepatology (2013) 1.93

Focal lesions in cirrhotic explant livers: pathological evaluation and accuracy of pretransplantation imaging examinations. Liver Transpl (2002) 1.79

Congenital veno-venous malformations of the liver: widely variable clinical presentations. J Gastroenterol Hepatol (2007) 1.68

The histology of kidney transplant failure: a long-term follow-up study. Transplantation (2014) 1.61

Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial. Transplantation (2016) 1.59

Troponin I is a predictor of acute cardiac events in the immediate postoperative renal transplant period. Transplantation (2010) 1.45

Noncirrhotic presinusoidal portal hypertension is common in cystic fibrosis-associated liver disease. Hepatology (2011) 1.43

Lipid peroxidation products in machine perfusion of older donor kidneys. J Surg Res (2012) 1.42

Liver transplantation for unresectable hepatocellular carcinoma in normal livers. J Hepatol (2012) 1.42

The extent of vacuolation in non-heart-beating porcine donor liver grafts prior to transplantation predicts their viability. Liver Transpl (2008) 1.41

Pretransplant predictors of posttransplant adherence and clinical outcome: an evidence base for pretransplant psychosocial screening. Transplantation (2009) 1.38

Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules. Am J Surg Pathol (2006) 1.32

Duffy and Kidd blood group antigens: minor histocompatibility antigens involved in renal allograft rejection? Transfusion (2007) 1.31

Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med (2012) 1.26

Liver regeneration in acute severe liver impairment: a clinicopathological correlation study. Liver Int (2006) 1.24

Liver transplantation for hereditary hemorrhagic telangiectasia: Report of the European liver transplant registry. Ann Surg (2006) 1.20

Machine perfusion versus cold storage for the preservation of kidneys donated after cardiac death: a multicenter, randomized, controlled trial. Ann Surg (2010) 1.17

MELD score to predict outcome in adult patients with non-acetaminophen-induced acute liver failure. Liver Int (2007) 1.13

The balance of risk score for allocation in liver transplantation. Ann Surg (2014) 1.11

Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients. Clin Pharmacokinet (2004) 1.06

A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma. BMC Cancer (2010) 1.06

Inhibitory and stimulatory effects of cyclosporine A on the development of regulatory T cells in vivo. Transplantation (2005) 1.01

Patient outcomes in two steroid-free regimens using tacrolimus monotherapy after daclizumab induction and tacrolimus with mycophenolate mofetil in liver transplantation. Transplantation (2008) 0.96

Liver transplantation using Donation after Cardiac Death donors. J Hepatol (2011) 0.92

Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: incidence, clinicopathological characteristics and prognostic factors. Leuk Lymphoma (2013) 0.90

The predictive value of kidney allograft baseline biopsies for long-term graft survival. J Am Soc Nephrol (2013) 0.89

The unrecognized posterior gastric artery: a potential cause of surgical complications in pancreas transplantation. Clin Transplant (2004) 0.89

Circulating AST, H-FABP, and NGAL are early and accurate biomarkers of graft injury and dysfunction in a preclinical model of kidney transplantation. Ann Surg (2011) 0.89

The value of machine perfusion perfusate biomarkers for predicting kidney transplant outcome. Transplantation (2010) 0.88

Machine perfusion versus cold storage for the preservation of kidneys from donors ≥ 65 years allocated in the Eurotransplant Senior Programme. Nephrol Dial Transplant (2012) 0.87

Clinicopathological features of focal nodular hyperplasia-like nodules in 130 cirrhotic explant livers. Am J Gastroenterol (2006) 0.86

Livers from non-heart-beating donors tolerate short periods of warm ischemia. Transplantation (2005) 0.86

The accuracy of positron emission tomography in the detection of posttransplant lymphoproliferative disorder. Haematologica (2012) 0.85

Giant liver hemangioma: the role of female sex hormones and treatment. Eur J Gastroenterol Hepatol (2011) 0.85

The role of bile salt toxicity in the pathogenesis of bile duct injury after non-heart-beating porcine liver transplantation. Transplantation (2008) 0.85

Systemic complement activation in deceased donors is associated with acute rejection after renal transplantation in the recipient. Transplantation (2011) 0.84

Multifactorial biological modulation of warm ischemia reperfusion injury in liver transplantation from non-heart-beating donors eliminates primary nonfunction and reduces bile salt toxicity. Ann Surg (2009) 0.84

Are TIPS stent-grafts a contraindication for future liver transplantation? Cardiovasc Intervent Radiol (2004) 0.84

Liver transplantation from donation after cardiac death donors: initial Belgian experience 2003-2007. Transpl Int (2009) 0.83

Hepatic immunohistochemical staining with a monoclonal antibody against HCV-E2 to evaluate antiviral therapy and reinfection of liver grafts in hepatitis C viral infection. J Hepatol (2003) 0.83

Preserving the morphology and evaluating the quality of liver grafts by hypothermic machine perfusion: a proof-of-concept study using discarded human livers. Liver Transpl (2012) 0.83

Functional beta-cell mass and insulin sensitivity is decreased in insulin-independent pancreas-kidney recipients. Transplantation (2009) 0.83

From vascular corrosion cast to electrical analog model for the study of human liver hemodynamics and perfusion. IEEE Trans Biomed Eng (2010) 0.83

Primary graft nonfunction and Kupffer cell activation after liver transplantation from non-heart-beating donors in pigs. Liver Transpl (2007) 0.83

Progressive multifocal leukoencephalopathy in liver transplant recipients: a case report and review of the literature. Transpl Int (2010) 0.82

Outcome of patients with hepatocellular carcinoma listed for liver transplantation within the Eurotransplant allocation system. Liver Transpl (2008) 0.82

Early presence of regulatory cells in transplanted rats rendered tolerant by donor-specific blood transfusion. J Immunol (2005) 0.81

Kidney donation after circulatory death in a country with a high number of brain dead donors: 10-year experience in Belgium. Transpl Int (2012) 0.81

Differential effect of diarrhea on FK506 versus cyclosporine A trough levels and resultant prevention of allograft rejection in renal transplant recipients. Am J Transplant (2002) 0.81

Artificial circulation of the liver: machine perfusion as a preservation method in liver transplantation. Anat Rec (Hoboken) (2008) 0.80

Management of posttransplant lymphoproliferative disorders following solid organ transplant: an update. Leuk Lymphoma (2011) 0.80

Machine perfusion in organ transplantation: a tool for ex-vivo graft conditioning with mesenchymal stem cells? Curr Opin Organ Transplant (2013) 0.79

Machine perfusion versus static cold storage in expanded criteria donor kidney transplantation: 3-year follow-up data. Transpl Int (2013) 0.79

Early accumulation of interferon-gamma in grafts tolerized by donor-specific blood transfusion: friend or enemy? Transplantation (2004) 0.79

Prothrombin complex concentrate in the reduction of blood loss during orthotopic liver transplantation: PROTON-trial. BMC Surg (2013) 0.79

Primary sclerosing cholangitis complicated by amyloid A amyloidosis: complete regression of the nephrotic syndrome by liver transplantation. Eur J Gastroenterol Hepatol (2010) 0.79

The Efficacy of Noble Gases in the Attenuation of Ischemia Reperfusion Injury: A Systematic Review and Meta-Analyses. Crit Care Med (2016) 0.78

Histology obtained by needle biopsy gives additional information on the prognosis of hepatocellular carcinoma. Hepatol Res (2012) 0.78

Intestinal failure: autologous reconstruction, intestinal transplantation and intestinal ischemia reperfusion injury. Curr Opin Organ Transplant (2013) 0.78

Decision making in pretransplant nephrectomy for polycystic kidneys, is it valid for horseshoe kidneys? Transpl Int (2012) 0.78

Regulatory cell-mediated tolerance does not protect against chronic rejection. Transplantation (2003) 0.78

Flow competition between hepatic arterial and portal venous flow during hypothermic machine perfusion preservation of porcine livers. Int J Artif Organs (2012) 0.78

Reperfusion of liver graft during transplantation: techniques used in transplant centres within Eurotransplant and meta-analysis of the literature. Transpl Int (2013) 0.78

Post-serial transverse enteroplasty bowel redilatation treated by longitudinal intestinal lengthening and tailoring procedure. J Pediatr Surg (2012) 0.78

Assessing warm ischemic injury of pig livers at hypothermic machine perfusion. J Surg Res (2013) 0.78

Machine perfusion in clinical trials: "machine vs. solution effects". Transpl Int (2012) 0.77

FTY720, an immunosuppressant that alters lymphocyte trafficking, abrogates chronic rejection in combination with cyclosporine A. Transplantation (2003) 0.77

Renal cell carcinoma in the allograft: what is the role of polyomavirus? Case Rep Nephrol Urol (2012) 0.77

Secondary effects of immunosuppressive drugs after simultaneous pancreas-kidney transplantation. Nephrol Dial Transplant (2005) 0.77

Heterozygous α1-antitrypsin Z allele mutation in presumed healthy donor livers used for transplantation. Eur J Gastroenterol Hepatol (2013) 0.77

Orlistat treatment is safe in overweight and obese liver transplant recipients: a prospective, open label trial. Transpl Int (2006) 0.77

Liver Transplantation for Hepatic Trauma: A Study From the European Liver Transplant Registry. Transplantation (2016) 0.77

Paradoxical early upregulation of intragraft Th1 cytokines is associated with graft acceptance following donor-specific blood transfusion. Transpl Int (2003) 0.76

Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients: A Guidance Report and Clinical Checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) Group. Transplantation (2017) 0.76

Time to think out of the (ice) box. Curr Opin Organ Transplant (2010) 0.75

Left ventricular assist device as bridge to liver transplantation in a patient with propionic acidemia and cardiogenic shock. J Pediatr (2011) 0.75

Alpers syndrome presenting with anatomopathological features of fulminant autoimmune hepatitis. J Inherit Metab Dis (2010) 0.75

Improving the function of liver grafts exposed to warm ischemia by the Leuven drug protocol: exploring the molecular basis by microarray. Liver Transpl (2012) 0.75

Hepatic Epithelioid Hemangioendothelioma and Adult Liver Transplantation: Proposal for a Prognostic Score Based on the Analysis of the ELTR-ELITA Registry. Transplantation (2017) 0.75

"Model for Early Allograft Function" outperforms "Early Allograft Dysfunction" as a predictor of transplant survival. Transplantation (2017) 0.75

Defining Benchmarks in Liver Transplantation: A Multicenter Outcome Analysis Determining Best Achievable Results. Ann Surg (2017) 0.75

An uncommon tumor in a renal graft recipient: a diagnostic and therapeutic challenge. Am J Kidney Dis (2002) 0.75

Portal hypertension after combined liver and intestinal transplantation, a diagnostic and therapeutic challenge? Pediatr Transplant (2012) 0.75

Implementation of an intervention plan designed to optimize donor referral in a donor hospital network. Prog Transplant (2006) 0.75

Advancing Transplantation: New Questions, New Possibilities in Kidney and Liver Transplantation. Transplantation (2017) 0.75

Organ Procurement and Transplantation in Belgium. Transplantation (2017) 0.75

Should the law on anonymity of organ donation be changed? The perception of liver transplant recipients. Clin Transplant (2009) 0.75

HEPATIC EPITHELIOID HEMANGIO-ENDOTHELIOMA AND ADULT LIVER TRANSPLANTATION: PROPOSAL FOR A PROGNOSTIC SCORE BASED ON THE ANALYSIS OF THE ELTR-ELITA REGISTRY. Transplantation (2016) 0.75

Reducing Non-Anastomotic Biliary Strictures in Donation After Circulatory Death Liver Transplantation: Cold Ischemia Time Matters! Ann Surg (2017) 0.75

Plasmatic villin 1 is a novel in vivo marker of proximal tubular cell injury during renal ischemia-reperfusion. Transplantation (2017) 0.75

Aplastic anemia after transplantation for non-A, non-B, non-C fulminant hepatic failure: case report and review of the literature. Transpl Int (2002) 0.75

Adult Liver Allocation in Eurotransplant. Transplantation (2017) 0.75

Intestinal ischemia reperfusion and lipopolysaccharide transform a tolerogenic signal into a sensitizing signal and trigger rejection. Transplantation (2009) 0.75